15. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie
20.11. - 21.11.2008, Bonn
Integration of primary and secondary data
Meeting Abstract
(08gaa01)
[Volltext]
Prevalence of depression in type II diabetics may be triggered mainly by co-morbidities rather than by diabetes mellitus itself
von Vultée C, Kostev K, Schröder-Bernhardi D[Volltext]
Meeting Abstract
(08gaa02)
[Volltext]
Do defined daily doses (DDDs) reflect prescribing behaviour? A 3-month-analysis of data from a statutory health insurance company
Grimmsmann T, Himmel W[Volltext]
Meeting Abstract
(08gaa03)
[Volltext]
Assessment of pharmacotherapy and evaluation of blood pressure control in patients above age 65 with hypertension in German primary care: Results of the DETECT study
Labeit A, Klotsche J, Pieper L, Wehling M, Wittchen HU[Volltext]
Meeting Abstract
(08gaa04)
[Volltext]
Cost advantages and improved patient treatment satisfaction with Insulin Glargine in Typ 2 Diabetes patients. The long-acting Insulin Glargine vs. NPH Insulin cost evaluation study in Germany (LIVE-DE)
Kohlmann T, Knollmeyer J, Landgraf W, Pirk O, Hauner H[Volltext]
Meeting Abstract
(08gaa05)
Mit Erratum (18.11.2008)
[Volltext]
Psychotropic drug prescribing for patients with newly diagnosed Alzheimer disease in 2002-2003. Analysis of the SHI-Sample AOK Hesse/KV Hesse
Küsgens I, Küpper-Nybelen J, Schubert IMit Erratum (18.11.2008)
[Volltext]
Meeting Abstract
(08gaa06)
[Volltext]
Cross National Comparison of Drug Utilization Research – Results from the ISPE / EuroDURG Project
Vlahovic-Palcevski V, Janhsen K, Elseviers M, Vander Stichele R[Volltext]
